The Psychedelic Medicine Coalition has partnered with prominent conservative lobbyists and consultants to bring federal funding to psychedelic research.
SB 58, the California legislation which would decriminalize certain psychedelic substances, is now being considered by the state Assembly after being passed by the Senate.
SB 58, legislation which would decriminalize certain psychedelic substances, has been advanced by the California Senate Public Safety Committee despite expected opposition.
Initiatives towards psychedelic policy reform are taking place in Europe, from a conference on psychedelic-assisted therapies at the European Parliament to the British Treasury’s approval of funding for innovative medical treatments.
An unusual coalition, including an Illinois state legislator and a local Psychedelic Society, has created the proposed CURE Act to legalize psilocybin therapy.
The medical model proposal, which would set up a framework for psilocybin-assisted therapy in New York ahead of FDA approval, is viewed by some policy reform advocates as the necessary next step towards decriminalization.
The recent spate of prosecuted ceremony leaders highlights tensions in Spain between medical and indigenous perspectives on psychedelics.
Pat Burke will introduce legislation to legalize psychedelic-assisted therapy following Linda Rosenthal’s bill to legalize possession of psychedelic plants and fungi.
State Senator Scott Wiener’s bill picks up where last year’s bill left off, but does not include synthetic substances like MDMA and LSD.
Advocates for the initiative, including two retired generals, say that the proposed inter-agency federal task force would support a thoughtful and coordinated introduction of psychedelic medicine services nationwide.